Posts in: March, 2017

What to Expect Next in Health Care Policy

This memorandum titled What to Expect Next in Health Care Policy provides insight on what to expect next in health care policy following last week’s

30 Mar

President Trump’s 2018 Budget

Here is a memo summarizing the Trump administration’s proposed budget for FY 2018.  Notably, the budget lists funding for Ryan White providers as one of

21 Mar

HRSA Delays 340B Ceiling Price/Manufacturer CMP Rule to May 22, 2017

The Health Resources and Services Administration (HRSA) has delayed until May 22, 2017 the effective date of the 340B Drug Pricing Program Ceiling Price and

17 Mar

AIR-340B Allies Ask Congress to Change the 340B Program

The Alliance for Integrity and Reform of 340B (AIR-340B), an advocacy group funded by the pharmaceutical industry and oncologists, has told Congress how to scale

10 Mar

ACA Repeal and Replace

House Republicans released last night a draft plan for repeal and replace of the Affordable Care Act (ACA).  The House Energy and Commerce Committee and

7 Mar

GAO Reviewing 340B Contract Pharmacy Arrangements

The U.S. Government and Accountability Office (GAO) is examining 340B contract pharmacy arrangements, although we do not yet know the purpose of the GAO’s review. 

1 Mar

Manufacturers Increase WAC Prices for HIV Medications

Several manufacturers of leading antiretroviral drugs increased wholesale acquisition cost (WAC) prices at the beginning of this year, despite an open letter submitted by the

1 Mar
Top